Lymphedema After Gynecologic Cancer Treatment
Lymphedema After Gyneco-oncologic Treatment
Recruiting
N/A
Interventional Study
Lymphedema
Genital Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 99
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 218 (estimated)
- Sponsor
- University Hospital, Ghent · Other
Who this trial is looking for
This trial is looking for women who have been recently diagnosed with gynecologic cancer and are starting treatment. Participants will help researchers understand the risk of developing lymphedema in their legs after treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with gynecologic cancer.
- I am female.
- I am at least 18 years old.
- I understand the Dutch language.
- I am willing to participate in the study and complete questionnaires.
You may not be able to join if
- I have had treatment for gynecologic cancer before.
- I have another type of cancer at the same time.
- I am pregnant or planning to get pregnant within the next 2 years.
- I have known cancer that has spread at the time of joining.
- I have had severe injury or surgery on my legs or groin in the past.
- I have circulation problems in my leg that have not been treated.
- I have mental or psychological problems that prevent me from participating.
- I started my first treatment more than 2 weeks ago.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Trial developed to inventory the incidence of early and advanced stage lower limb lymphedema in patients diagnosed with and treated for gynaecologic cancer.
Four hundred patients with diagnosis stage 1-3 gynaecologic cancer will be included in an observational cohort between diagnosis until maximum 2 weeks after start of the first treatment. They will be followed for occurrence of lower limb lymp…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Signed informed consent (ICF)
* Female patient, recently diagnosed with gynaecologic cancer (cervix, endometrium, vulva, vagina, ovaries…) and candidate for curative treatment
* Age ≥ 18 years
* Understanding of the Dutch language
* Able to understand the informed consent and …
Contacts